Pembrolizumab vs investigator-choice chemotherapy for previously treated advanced urothelial cancer: Phase 3 KEYNOTE-045 study

Authors :: Howard Gurney
Toni K. Choueiri
Markus Puhlmann
Nicholas J. Vogelzang
Miguel Angel Climent
Yves Fradet
Lawrence Fong
David I. Quinn
Daniel P. Petrylak
Stéphane Culine
J.-L. Lee
Dean F. Bajorin
Yabing Mai
Winald R. Gerritsen
Andrea Necchi
David J. Vaughn
Cora N. Sternberg
Rodolfo F. Perini
R. de Wit
Joaquim Bellmunt
Source :: European Journal of Cancer. 72:S2
Publication Year :: 2017
Publisher :: Elsevier BV, 2017.

Subjects :: 0301 basic medicine
Oncology
Cancer Research
medicine.medical_specialty
Chemotherapy
business.industry
medicine.medical_treatment
Pembrolizumab
03 medical and health sciences
030104 developmental biology
Internal medicine
Medicine
Urothelial cancer
business
Previously treated

Full Text Access

Tools